{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:25:18Z","timestamp":1760909118709,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:00:00Z","timestamp":1528675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s12094-018-1905-5","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T10:53:05Z","timestamp":1528714385000},"page":"187-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Bloodstream infection in patients with head and neck cancer: a major challenge in the cetuximab era"],"prefix":"10.1007","volume":"21","author":[{"given":"M.","family":"Mar\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3095-4422","authenticated-orcid":false,"given":"C.","family":"Gudiol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Castet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Peir\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Royo-Cebrecos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Carratal\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mesia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,11]]},"reference":[{"key":"1905_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2017.04.004","author":"M Ma\u00f1os","year":"2017","unstructured":"Ma\u00f1os M, Giralt J, Rueda A, Cabrera J, Martinez-Trufero J, Marruecos J, et al. Multidisciplinary management of head and neck cancer: first expert consensus using Delphi methodology from the Spanish society for head and neck cancer (part 1). Oral Oncol. 2017. \n                    https:\/\/doi.org\/10.1016\/j.oraloncology.2017.04.004\n                    \n                  .","journal-title":"Oral Oncol"},{"key":"1905_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2017.04.005","author":"A Rueda","year":"2017","unstructured":"Rueda A, Giralt J, Ma\u00f1os M, Lozano A, Sistiaga A, Garcia-Miragall E, et al. Multidisciplinary management of head and neck cancer: first expert consensus using Delphi methodology from the Spanish society for head and neck cancer (part 2). Oral Oncol. 2017. \n                    https:\/\/doi.org\/10.1016\/j.oraloncology.2017.04.005\n                    \n                  .","journal-title":"Oral Oncol"},{"key":"1905_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mayocp.2015.12.017","volume":"91","author":"S Marur","year":"2016","unstructured":"Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91:386\u201396. \n                    https:\/\/doi.org\/10.1016\/j.mayocp.2015.12.017\n                    \n                  .","journal-title":"Mayo Clin Proc"},{"key":"1905_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/cid\/cir073","volume":"2011","author":"AG Freifeld","year":"2010","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer, update by the infectious diseases society of America. Clin Infect Dis. 2010;2011:52. \n                    https:\/\/doi.org\/10.1093\/cid\/cir073\n                    \n                  .","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"1905_CR5","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1086\/383050","volume":"39","author":"J Klastersky","year":"2004","unstructured":"Klastersky J. Management of fever in neutropenic patients with different risks of complications. Clin Infect Dis. 2004;39(Suppl 1):S32\u20137.","journal-title":"Clin Infect Dis"},{"key":"1905_CR6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","volume":"32","author":"E Montassier","year":"2013","unstructured":"Montassier E, Batard E, Gastinne T, Potel G, De La Cocheti\u00e8re MF. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis. 2013;32:841\u201350.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1905_CR7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/jac\/dkq494","volume":"66","author":"C Gudiol","year":"2011","unstructured":"Gudiol C, Tubau F, Calatayud L, Garcia-Vidal C, Cisnal M, S\u00e1nchez-Ortega I, et al. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother. 2011;66:657\u201363.","journal-title":"J Antimicrob Chemother"},{"key":"1905_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s15010-004-3049-5","volume":"32","author":"M Anatoliotaki","year":"2004","unstructured":"Anatoliotaki M, Valatas V, Mantadakis E, Apostolakou H, Mavroudis D, Georgoulias V, et al. Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome. Infection. 2004;32:65\u201371.","journal-title":"Infection"},{"key":"1905_CR9","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/jac\/dkt002","volume":"68","author":"S Schelenz","year":"2013","unstructured":"Schelenz S, Nwaka D, Hunter PR. Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance. J Antimicrob Chemother. 2013;68:1431\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"1905_CR10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354:567\u201378.","journal-title":"N Engl J Med"},{"key":"1905_CR11","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","volume":"359","author":"JB Vermorken","year":"2008","unstructured":"Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 2008;359:1116\u201327.","journal-title":"N Engl J Med"},{"key":"1905_CR12","doi-asserted-by":"publisher","first-page":"e50163","DOI":"10.1371\/journal.pone.0050163","volume":"7","author":"CC Lee","year":"2012","unstructured":"Lee CC, Ho HC, Hsiao SH, Huang TT, Lin HY, Li SC, et al. Infectious complications in head and neck cancer patients treated with cetuximab: propensity score and instrumental variable analysis. PLoS One. 2012;7:e50163. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0050163\n                    \n                  .","journal-title":"PLoS One"},{"key":"1905_CR13","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.ctrv.2014.09.002","volume":"40","author":"T Funakoshi","year":"2014","unstructured":"Funakoshi T, Suzuki M, Tamura K. Infectious complications in cancer patients treated with anti-EGFR monoclonal antibodies cetuximab and panitumumab: a systematic review and meta-analysis. Cancer Treat Rev. 2014;40:1221\u20139.","journal-title":"Cancer Treat Rev"},{"key":"1905_CR14","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00520-014-2466-y","volume":"23","author":"R Berardi","year":"2015","unstructured":"Berardi R, Rinaldi S, Santini D, Vincenzi B, Giampieri R, Maccaroni E, et al. Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis. Support Care Cancer. 2015;23:1295\u2013302.","journal-title":"Support Care Cancer"},{"key":"1905_CR15","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245\u201351.","journal-title":"J Clin Epidemiol"},{"key":"1905_CR16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","volume":"137","author":"ND Friedman","year":"2002","unstructured":"Friedman ND, Kaye KS, Stout JE, McGarry S, et al. Health care-associated bloodstream infections in adults : a reason to change the accepted definiti. Ann Intern Med. 2002;137:791\u20137.","journal-title":"Ann Intern Med"},{"key":"1905_CR17","doi-asserted-by":"publisher","first-page":"A274","DOI":"10.1016\/S1098-3015(11)72017-4","volume":"13","author":"E Basch","year":"2010","unstructured":"Basch E, Reeve B, Cleeland C, Sloan J, Schrag D, Atkinson TM, et al. Development of the patient-reported version of the common terminology criteria for adverse events (pro-CTCAE). Value Heal. 2010;13:A274\u20135.","journal-title":"Value Heal"},{"key":"1905_CR18","doi-asserted-by":"crossref","unstructured":"RS M. Sepsis, severe sepsis, and septic shock. 2010. https:\/\/doi.org\/10.1016\/b978-0-443-06839-3.00070-9.","DOI":"10.1016\/B978-0-443-06839-3.00070-9"},{"key":"1905_CR19","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100S. 2016."},{"key":"1905_CR20","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1099\/jmm.0.46747-0","volume":"55","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol. 2006;55:1619\u201329.","journal-title":"J Med Microbiol"},{"key":"1905_CR21","unstructured":"EUCAST. Breakpoint tables for interpretation of MICs and zone diameters European Committee on antimicrobial susceptibility testing breakpoint tables for interpretation of MICs and zone diameters. EUCAST 2016:35\u201344."},{"key":"1905_CR22","doi-asserted-by":"publisher","unstructured":"Hosmer DW, Lemeshow S SR. Applied logistic regression, 3rd edition. 2013. \n                    https:\/\/doi.org\/10.1002\/9781118548387\n                    \n                  .","DOI":"10.1002\/9781118548387"},{"key":"1905_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/MD.0000000000000026","volume":"93","author":"M Mar\u00edn","year":"2014","unstructured":"Mar\u00edn M, Gudiol C, Garcia-Vidal C, Ardanuy C, Carratal\u00e0 J. Bloodstream infections in patients with solid tumors. Med Baltim. 2014;93:143\u20139.","journal-title":"Med Baltim"},{"key":"1905_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jinf.2012.12.007","volume":"66","author":"D Viasus","year":"2013","unstructured":"Viasus D, Garcia-Vidal C, Simonetti A, Manresa F, Dorca J, Gudiol F, et al. Prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia. J Infect. 2013;66:415\u201323.","journal-title":"J Infect"},{"key":"1905_CR25","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/CCM.0b013e3181ffe217","volume":"39","author":"AP Delaney","year":"2011","unstructured":"Delaney AP, Dan A, McCaffrey J, Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis*. Crit Care Med. 2011;39:386\u201391.","journal-title":"Crit Care Med"},{"key":"1905_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jcrc.2015.12.019","volume":"33","author":"A Artigas","year":"2016","unstructured":"Artigas A, Wernerman J, Arroyo V, Vincent JL, Levy M. Role of albumin in diseases associated with severe systemic inflammation: pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis. J Crit Care. 2016;33:62\u201370.","journal-title":"J Crit Care"},{"key":"1905_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1086\/649537","volume":"50","author":"J Rodr\u00edguez-Ba\u00f1o","year":"2010","unstructured":"Rodr\u00edguez-Ba\u00f1o J, Pic\u00f3n E, Gij\u00f3n P, Hern\u00e1ndez JR, Ru\u00edz M, Pe\u00f1a C, et al. Community-onset bacteremia due to extended-spectrum \u03b2-lactamase\u2013producing Escherichia coli: risk factors and prognosis. Clin Infect Dis. 2010;50:40\u20138.","journal-title":"Clin Infect Dis"},{"key":"1905_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10096-007-0320-6","volume":"26","author":"I Raad","year":"2007","unstructured":"Raad I, Hachem R, Hanna H, Bahna P, Chatzinikolaou I, Fang X, et al. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis. 2007;26:549\u201356.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1905_CR29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cmi.2015.01.029","volume":"21","author":"M Marin","year":"2015","unstructured":"Marin M, Gudiol C, Ardanuy C, Garcia-Vidal C, Jimenez L, Domingo-Domenech E, et al. Factors influencing mortality in neutropenic patients with haematologic malignancies or solid tumours with bloodstream infection. Clin Microbiol Infect. 2015;21:583\u201390.","journal-title":"Clin Microbiol Infect"},{"key":"1905_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijantimicag.2007.06.012","volume":"30","author":"J Klastersky","year":"2007","unstructured":"Klastersky J, Ameye L, Maertens J, Georgala A, Muanza F, Aoun M, et al. Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents. 2007;30:51\u20139.","journal-title":"Int J Antimicrob Agents"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-018-1905-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-018-1905-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-018-1905-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T11:06:35Z","timestamp":1568027195000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-018-1905-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,11]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1905"],"URL":"https:\/\/doi.org\/10.1007\/s12094-018-1905-5","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"type":"print","value":"1699-048X"},{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2018,6,11]]},"assertion":[{"value":"18 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This observational study was approved by the Institutional Review Board Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica del Hospital Universitari de Bellvitge (Ethics Committee of Clinical Research-Hospital Universitari de Bellvitge). To protect personal privacy, identifying information of each patient in the electronic database was encrypted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived by the Clinical Research Ethics Committee because no intervention was involved and no patient identifying information was included.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}